Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has announced the offering of a new financial instrument, the Trigger Jump Securities based on the Class C Common Stock of Dell Technologies Inc., with a maturity date set for September 2026. These securities are principal at risk and do not guarantee a fixed return. Instead, the payout at maturity is contingent on the performance of Dell's stock, with potential returns ranging from a fixed amount if Dell's stock price remains stable or appreciates, to no minimum payment if the stock depreciates by more than 10% from the initial share price. The securities are unsecured debt obligations of Citigroup Global Markets Holdings Inc. and are fully and unconditionally guaranteed by...Show More

Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has announced the offering of a new financial instrument, the Trigger Jump Securities based on the Class C Common Stock of Dell Technologies Inc., with a maturity date set for September 2026. These securities are principal at risk and do not guarantee a fixed return. Instead, the payout at maturity is contingent on the performance of Dell's stock, with potential returns ranging from a fixed amount if Dell's stock price remains stable or appreciates, to no minimum payment if the stock depreciates by more than 10% from the initial share price. The securities are unsecured debt obligations of Citigroup Global Markets Holdings Inc. and are fully and unconditionally guaranteed by Citigroup Inc. They do not pay interest and will not be listed on any securities exchange, indicating that liquidity may be limited. The offering is expected to be priced on September 10, 2024, and issued on September 13, 2024. Citigroup Global Markets Inc., an affiliate of the issuer, will act as the underwriter and may profit from expected hedging activities related to this offering. The securities are not bank deposits and are not insured by any governmental agency. The SEC has not approved or disapproved the securities, nor have they passed upon the accuracy of the supplements. Investors are advised to read the accompanying product supplement, prospectus supplement, and prospectus in deciding whether to invest in the securities.